Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Gritstone Oncology Inc (GRTS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Gritstone Oncology's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.714 -0.030    -4.02%
15:26:22 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,343,812
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.709 - 0.775
Gritstone Oncology 0.714 -0.030 -4.02%

GRTS Income Statement

 
Featured here, the Income Statement (earnings report) for Gritstone Oncology Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 10.38 1.56 1.96 2.44
Revenue 0.029 0.361 0.4 0.542
Other Revenue, Total 10.35 1.2 1.56 1.9
Cost of Revenue, Total 32.94 32.76 30.97 30.51
Gross Profit -22.56 -31.2 -29.01 -28.07
Total Operating Expenses 40.85 40.17 37.68 37.26
Selling/General/Admin. Expenses, Total 7.92 7.41 6.72 6.74
Research & Development 32.94 32.76 30.97 30.51
Depreciation / Amortization 0.021 -0.036 -0.193 0.199
Interest Expense (Income) - Net Operating -1.22 -0.991 -0.985 -0.844
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -31.74 -31.74 -29.79 -29.87
Operating Income -30.47 -38.6 -35.73 -34.82
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 0.347 -0.17 -0.472 -0.834
Net Income Before Taxes -30.82 -38.43 -35.26 -33.98
Provision for Income Taxes - - - -
Net Income After Taxes -30.82 -38.43 -35.26 -33.98
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -30.82 -38.43 -35.26 -33.98
Total Extraordinary Items - - - -
Net Income -30.82 -38.43 -35.26 -33.98
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -30.82 -38.43 -35.26 -33.98
Dilution Adjustment 0.143 - - -
Diluted Net Income -30.96 -38.43 -35.26 -33.98
Diluted Weighted Average Shares 117.42 115.34 114.93 114.42
Diluted EPS Excluding Extraordinary Items -0.264 -0.333 -0.307 -0.297
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.164 -0.208 -0.192 -0.186
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GRTS Comments

Write your thoughts about Gritstone Oncology Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
LUCA LIETO
LUCA LIETO Mar 01, 2024 5:10AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The impact of work force reduction on subsequent performance in major mergers and acquisitions: An exploratory study
Gerald Broflowski
Gerald Broflowski Mar 13, 2022 10:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sold, this is dead money
Ed Bostridge
Ed Bostridge Mar 13, 2022 10:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
thanks for the buy signal
Gerald Broflowski
Gerald Broflowski Mar 13, 2022 10:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ed Bostridge  you are welcome loser :D
Gerald Broflowski
Gerald Broflowski Jan 24, 2022 7:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looks like it is bankrupt. But they have 230M cash. ******
Ed Bostridge
Ed Bostridge Jan 04, 2022 1:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to catch the knife
Avise Analytics
Avise Aug 23, 2021 9:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.reddit.com/r/MicrocapStocksRun/comments/p9yjqj/grts_should_gritstone_bio_be_a_part_of_your/?utm_source=share&utm_medium=web2x&context=3
Gerald Broflowski
Gerald Broflowski Apr 27, 2021 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Soon this will be 3 digits. Now $9.94
Gerald Broflowski
Gerald Broflowski Apr 27, 2021 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
well, don´t listen to me short term, now it is 7.88 and I sit in a loss...
Zoran Labus
Zoran Labus Mar 25, 2021 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Andreas Lodsborg
Andreas Lodsborg Feb 17, 2021 1:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Waiting for FDA. 100$
Nikola Labovic
Nikola Labovic Jan 28, 2021 8:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BIG BIG BIG DISCOUNTS AT $BNGO $GEVO and $GRTS !!!  Lets do this rebels! #walstreetbets #reddit
Harold Kumar
Harold Kumar Nov 23, 2020 1:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Get it
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email